chevron_leftBack
As of 20 June 2026, Zenotech Laboratories Ltd. has a market cap of $29.44M USD, ranking #34370 globally and #2342 in India.
It ranks #3106 in the Healthcare sector, and #1056 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$29.44MUSD
2.78B INR
Enterprise Value
$26.07MUSD
2.46B INR
Revenue (TTM)
$4.44MUSD
419.33M INR
EBITDA (TTM)
$1.42MUSD
134.1M INR
Net Income (TTM)
$356.17KUSD
33.62M INR
EBITDA Margin
32%
Profit Margin
8%
PE Ratio
82.8
PS Ratio
6.6
PB Ratio
2.9
EV/EBITDA
18.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sachin Gavandare
open_in_new
Employees
228
Founded
1989
Website
zenotechlab.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.2% | -2.4% | 28% | 2.8% | -11% | -22% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
532039
(ZENOTECH)
Zenotech Laboratories Ltd
ISIN: INE486F01012
Shares Out.:
Shares Outstanding:
61.031M1
Shares Float:
19.016M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
45.53 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zenotech Laboratories Ltd.
Zenotech Laboratories Limited manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It offers contract manufacturing services for parenteral depot formulations, ophthalmic, oncology oral and injectables, and general injectables. The company also leases out its biotech facility and equipment. In addition, it provides granulocyte-colony stimulating factor and granulocyte-macrophage colony-stimulating factor products. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
153K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
62K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
51K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
40K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
33K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
33K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
3M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
2M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
1M%
|
97.4
|
|
SIX: RO
|
$318.3B
1M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
967K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
931K%
|
15.1
|
chevron_leftBack